
NVIDIA's BioNeMo Platform Secures Eli Lilly Partnership as Biotech AI Competition Intensifies
NVIDIA's BioNeMo platform has secured partnerships with Eli Lilly, Thermo Fisher, and TetraScience for AI-driven drug discovery infrastructure.<sup>1</sup> The deals arrive as competing biotech AI firms including Natera, Basecamp Research, Boltz Lab, Owkin, and Edison Scientific launch rival foundation model platforms, signaling an infrastructure land-grab phase in pharmaceutical AI.
















